Quick Links GLP2 The Imbalanced Dual Incretin Agonist Also known as: LY3298176 Why Researchers Choose GLP2-T Unlike selective GLP-1 receptor agonists, GLP2 peptide is engineered with an imbalanced receptor binding profilematching native GIP affinity while binding GLP-1 receptors with approximately 5-fold weaker affinity
Riool, M., de Breij, A., Kwakman, P., Schonkeren-Ravensbergen, E., de Boer, L., Cordfunke, R.A., et al., Biochem
Having a 4-year-old daughter, it's so exciting for me to be able to raise her in a way that I wish I had been raised
Sold as a food supplement rather than a licensed medicine, they are not subject to the same pre-market safety and efficacy standards as pharmaceutical products regulated by the MHRA
That's, that's always my Michelle Oravitz: Yeah, that's the hope
T 3 is three to five times more active than T 4